Oxidative stress. Calcium signaling. Animal tumors. Differences in cellular susceptibility. RF Safe’s position begins with findings that deserve investigation—and a public that deserves more than reassurance.
People keep asking a reasonable question: What is long-term wireless exposure doing to living systems?
Answering that question requires more than checking whether a device complies with an existing limit. It requires examining the research, understanding what different experiments actually measured, and investigating why some biological systems respond while others do not.
RF Safe has spent decades pursuing those questions.
Our research catalog now lists more than 6,000 paper records. Our public-comment archives have grown beyond 1,700 HHS submissions and nearly 600 FCC filings. People are reading, asking questions, and putting their concerns before federal agencies.
This is an opportunity to turn that interest into a stronger research agenda.
Submit your HHS comment before October 21, 2026.
Find the FCC filing instructions for ET Docket 13-84.
Start with what the research collection actually shows.
At the time of this review, RF Safe’s catalog listed 6,492 records. Its classifications included 1,462 labeled “harm,” 1,918 “mixed,” 614 “benefit,” and 629 “no effect.” Another 1,569 were “unclear,” and 300 lacked an extraction or classification.
That puts “no effect” at approximately 9.7% of the catalog. These are AI-assisted classifications for navigating the collection, rather than a quality-weighted scientific verdict.
The distinction matters. The remaining 90% cannot all be called proof of harm—or even proof of an electromagnetic effect. The collection spans different exposures, experimental designs, reviews, and technology-related health questions. A study of smartphone behavior, for example, cannot automatically establish an effect of RF radiation.
What the catalog provides is a way into a substantial literature. Readers can move beyond slogans and examine the original research.
“Mixed” findings deserve examination because an effect may appear in one outcome, exposure condition, or population and be absent in another. Beneficial effects deserve examination because they can reveal biological responsiveness under defined conditions. Neither category should automatically be converted into a claim of injury.
The important next question is what explains the response.
Oxidative stress is one of the clearest places to begin.
The researcher many readers will recognize is Igor Yakymenko.
In a review published online in 2015 and in a 2016 journal issue, Yakymenko and colleagues reported that 93 of 100 peer-reviewed studies they examined found oxidative effects from low-intensity radiofrequency radiation. The findings included changes involving reactive oxygen species, antioxidant systems, and markers of molecular damage.
To understand why that matters, think of a cell as a working system that must continuously balance energy production, signaling, maintenance, and repair.
Reactive oxygen species are part of normal biology. They help transmit signals and participate in defense. Trouble can arise when their production and the cell’s protective systems fall out of balance.
That is the concern behind oxidative stress: an alteration in a regulatory process that can, under some conditions, contribute to damage.
A measured oxidative response is therefore worth investigating. Its duration, magnitude, location, and functional consequences determine how much it tells us about health.
Henry Lai’s work helps reveal the broader pattern.
Lai has spent years compiling research across oxidative, genetic, neurological, and reproductive endpoints. His work makes it easier to see recurring findings that can disappear when public discussion focuses on a single study.
In their 2023 review, Lai and B. Blake Levitt describe EMF-associated cellular responses in terms of the broader cellular stress response and discuss altered oxidative processes as a possible contributor.
RF Safe sees this as a reason to investigate connections across endpoints: whether changes in redox regulation, calcium signaling, metabolism, and cellular recovery help explain apparently different observations.
Counting positive studies is useful for identifying a pattern. Establishing confidence requires additional work: exposure verification, temperature control, reliable assays, independent replication, and assessment of publication bias.
A 2024 systematic review reached very-low-certainty conclusions about RF exposure and oxidative-stress biomarkers, citing study limitations and substantial variation. That disagreement identifies an important research task: determine which findings survive stronger controls and which biological or exposure differences explain the variation.
RF Safe’s demand is that recurring findings lead to better experiments.
Cells depend on timing as well as chemistry.
Calcium is a useful example.
Cells use changes in calcium concentration as signals. The timing, duration, location, and repetition of those changes can influence the response. A brief pulse and a sustained elevation need not carry the same biological meaning.
Membrane voltage helps regulate cellular activity. Mitochondria participate in energy production, calcium handling, and redox regulation. These processes interact.
RF Safe uses “biological fidelity” to describe how reliably a cell or tissue performs a defined task: responding at the right time, maintaining a stable state, coordinating with neighboring cells, or recovering after a challenge.
“Low-fidelity biology” describes our proposed loss of that precision.
An everyday analogy is a conversation interrupted by a poorly timed sound. The issue is whether the interruption changes what the listener receives and does next. In biology, that analogy must become a measurable question about physical coupling, signaling, and function.
Our papers propose experiments to determine when such interference occurs, when the system compensates, and when there is no meaningful effect.
S4–Mito–Spin gives that question specific targets.
The framework brings together three candidate areas of investigation.
S4 refers to voltage-sensing segments in certain ion channels. RF Safe proposes investigating whether particular exposures can alter channel activity or timing. Direct coupling from weak environmental RF to these structures still requires demonstration.
Mito refers to mitochondrial processes that could amplify a disturbance or help the cell recover. More mitochondria do not automatically mean greater vulnerability; they can also support buffering and repair.
Spin refers to magnetic-field-sensitive chemistry involving electron spins and radical pairs. Demonstrations in particular experimental systems establish reasons to study those pathways, while leaving their relevance to everyday wireless exposures to be determined.
These are candidate routes, rather than a single mechanism already proven to explain every finding.
The framework becomes useful when it predicts an outcome before an experiment—and when disrupting a proposed pathway changes the outcome as predicted.
A no-effect study helps define the boundaries.
Different cells have different signaling machinery, metabolic demands, and recovery capacity. Different experiments use different waveforms, durations, intensities, and measurement times.
RF Safe’s “density gating” hypothesis asks whether independently measured features of the biological receiver help predict those differences.
The newer biological-fidelity paper makes an essential commitment: a negative result cannot automatically be declared confirmation of the framework. A proposed boundary must be specified and tested.
If the model predicts a response and a well-designed experiment finds none, the model must change.
That is how an explanation becomes scientifically useful.
Beneficial effects also tell us something—but something specific.
FDA’s TheraBionic P1 record offers a concrete example of deliberately applied, amplitude-modulated RF in medicine.
The device received authorization through a humanitarian device exemption for a specified advanced liver-cancer indication. FDA describes probable benefit and lists calcium-channel blockers among its contraindications.
This makes defined RF exposure and calcium-channel biology relevant subjects for investigation. It does not establish that ordinary wireless exposure reproduces the treatment’s effects.
The practical lesson is that waveform, delivery, target tissue, and biological state deserve attention. “Beneficial,” “harmful,” and “no detectable effect” describe different outcomes that a useful model should be able to distinguish.
Animal findings make the investigation more consequential.
The National Toxicology Program reported clear evidence of carcinogenic activity based on malignant heart schwannomas in male rats under its studied exposure conditions.
Those experiments used whole-body exposure levels and schedules that differ from ordinary human use. Their findings provide animal hazard evidence; they do not directly calculate an individual phone user’s risk.
RF Safe’s newer papers ask a focused follow-up question: what made the affected cells susceptible?
That requires studying the relevant cell lineage and its environment. A tumor arising from Schwann cells cannot be explained merely by pointing to the mitochondrial abundance of neighboring heart muscle.
This is the kind of distinction a serious research program should resolve.
The deeper question is whether exposure can change the next response.
RF Safe’s Cellular Latent Learning Model—ceLLM—asks whether repeated perturbations can leave a persistent regulatory state that changes how a cell responds later.
We call that proposed state a “meta-disease” state: a hypothesis about altered vulnerability across outcomes, rather than a clinical diagnosis.
The experiment is understandable.
Expose one group and maintain a properly matched sham group. Remove the exposure. Determine whether acute changes have resolved. Then give both groups the same subsequent challenge.
Does the previously exposed group respond differently? Does a measurable cellular state predict that difference? Can reversing that state reverse the altered response?
Those tests could support the hypothesis, narrow it, or reject it.
Our proposed planarian pilot addresses a simpler related question: whether a defined exposure changes the time needed for an established altered head shape to return toward species-typical form. That is an exploratory remodeling experiment, with blinded scoring and matched conditions—not an assumption that an observed change must be harmful.
RF Safe is asking for an experimental program with answers that can prove us wrong as well as right.
The policy request follows directly.
Our HHS response asks for sustained independent research, reviews organized by health outcome, better exposure measurements, and studies of susceptibility and recovery.
Our FCC materials ask the Commission to address the relevant health evidence before expanding reliance on existing compliance determinations as a complete answer to public concerns.
Our proposed Clean Aether Act adds a constructive technology agenda: research, reassessment of exposure protections, fiber and optical-connectivity pilots, and greater attention to siting near sensitive locations. It is a legislative proposal, not enacted law.
The goal is reliable communication developed alongside a serious effort to understand and reduce avoidable exposure.
That requires engineering, biology, public participation, and transparent decision-making.
Put the questions—and the evidence—into the record.
HHS is accepting responses through October 21, 2026. Its request specifically invites evidence about exposures below current limits, research gaps, susceptible populations, and possible improvements to assessment and regulation.
You can ask for independent replication of oxidative-stress findings. You can request studies that preserve waveform and timing information. You can recommend research on children, pregnancy, cumulative exposure, or recovery after repeated exposure.
If you report an experience, distinguish what you observed from what you believe caused it. If you cite research, explain what it measured and why it matters.
For the FCC, use ET Docket 13-84 and review the current notice and filing instructions. The October 21 date above is the HHS deadline.
Open the official FCC docket.
Use RF Safe’s FCC filing guide.
Explore the evidence and public record:
RF Safe research catalog
HHS public-comment archive
FCC public-comment archive
We the People can ask for research that measures the right things, tests competing explanations, and follows the evidence wherever it leads. Put that request in the record.
Disclosure: RF Safe has commercial interests in exposure-reduction accessories and electromagnetic technologies. Its biological-fidelity framework is a proposed research model, not a validated diagnostic system.
